Study on the Correlation Between NAT2(N-acetyltransferase2) Gene Polymorphism and CrCl(Creatine Clreance) and the Efficacy and Safety of Levosimendan in Patients With Severe Heart Failure
Clinical trial NCT05913271 · UNKNOWN
Trial details
- NCT number
- NCT05913271
- Sponsor
- Yi Han
- Status
- UNKNOWN
- Study type
- OBSERVATIONAL
- Start date
- 2023-05-30
- Primary completion
- 2025-05-30
- Enrollment
- 352
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.